Suranganie Dharmawardhane

Suranganie Dharmawardhane Flanagan is a Sri Lankan molecular biologist and biochemist. She is a professor of biochemistry at the University of Puerto Rico School of Medicine. Provided by Wikipedia
Showing 1 - 9 results of 9 for search 'Suranganie Dharmawardhane', query time: 0.04s Refine Results
  1. 1
    Anti-Breast Cancer Potential of Quercetin via the Akt/AMPK/Mammalian Target of Rapamycin (mTOR) Signaling Cascade.

    Anti-Breast Cancer Potential of Quercetin via the Akt/AMPK/Mammalian Target of Rapamycin (mTOR) Signaling Cascade. by Amilcar Rivera Rivera, Linette Castillo-Pichardo, Yamil Gerena, Suranganie Dharmawardhane

    Published 2016-01-01
    Get full text
    Article
  2. 2
    Rac and Cdc42 inhibitors reduce macrophage function in breast cancer preclinical models

    Rac and Cdc42 inhibitors reduce macrophage function in breast cancer preclinical models by Anamaris Torres-Sanchez, Anamaris Torres-Sanchez, Michael Rivera-Robles, Linette Castillo-Pichardo, Magaly Martínez-Ferrer, Magaly Martínez-Ferrer, Stephanie M. Dorta-Estremera, Stephanie M. Dorta-Estremera, Suranganie Dharmawardhane, Suranganie Dharmawardhane

    Published 2023-06-01
    Get full text
    Article
  3. 3
    Synthesis, Anti-Cancer and Anti-Migratory Evaluation of 3,6-Dibromocarbazole and 5-Bromoindole Derivatives

    Synthesis, Anti-Cancer and Anti-Migratory Evaluation of 3,6-Dibromocarbazole and 5-Bromoindole Derivatives by Krystal M. Butler-Fernández, Zulma Ramos, Adela M. Francis-Malavé, Joseph Bloom, Suranganie Dharmawardhane, Eliud Hernández

    Published 2019-07-01
    Get full text
    Article
  4. 4
    Rac inhibition as a novel therapeutic strategy for EGFR/HER2 targeted therapy resistant breast cancer

    Rac inhibition as a novel therapeutic strategy for EGFR/HER2 targeted therapy resistant breast cancer by Luis D. Borrero-García, Maria del Mar Maldonado, Julia Medina-Velázquez, Angel L. Troche-Torres, Luis Velazquez, Nilmary Grafals-Ruiz, Suranganie Dharmawardhane

    Published 2021-06-01
    Get full text
    Article
  5. 5
    Physiologically-Based Pharmacokinetic/Pharmacodynamic Model of MBQ-167 to Predict Tumor Growth Inhibition in Mice

    Physiologically-Based Pharmacokinetic/Pharmacodynamic Model of MBQ-167 to Predict Tumor Growth Inhibition in Mice by Javier Reig-López, María del Mar Maldonado, Matilde Merino-Sanjuan, Ailed M. Cruz-Collazo, Jean F. Ruiz-Calderón, Victor Mangas-Sanjuán, Suranganie Dharmawardhane, Jorge Duconge

    Published 2020-10-01
    Get full text
    Article
  6. 6
    Pharmacokinetics of the Rac/Cdc42 Inhibitor MBQ-167 in Mice by Supercritical Fluid Chromatography–Tandem Mass Spectrometry

    Pharmacokinetics of the Rac/Cdc42 Inhibitor MBQ-167 in Mice by Supercritical Fluid Chromatography–Tandem Mass Spectrometry by María del Mar Maldonado, Gabriela Rosado-González, Joseph Bloom, Jorge Duconge, Jean F. Ruiz-Calderón, Eliud Hernández-O’Farrill, Cornelis Vlaar, José F. Rodríguez-Orengo, Suranganie Dharmawardhane

    Published 2019-10-01
    Get full text
    Article
  7. 7
    Synthesis of Novel Heterocyclic Ferrocenyl Chalcones and Their Biological Evaluation

    Synthesis of Novel Heterocyclic Ferrocenyl Chalcones and Their Biological Evaluation by Ámbar M. Alsina-Sánchez, Sebastián Montalvo-Vázquez, Nilmary Grafals-Ruiz, Carmen Acosta, Emily M. Ormé, Israel Rodríguez, Sara M. Delgado-Rivera, Arthur D. Tinoco, Suranganie Dharmawardhane, Ingrid C. Montes-González

    Published 2023-09-01
    Get full text
    Article
  8. 8
    The Rac Inhibitor EHop-016 Inhibits Mammary Tumor Growth and Metastasis in a Nude Mouse Model

    The Rac Inhibitor EHop-016 Inhibits Mammary Tumor Growth and Metastasis in a Nude Mouse Model by Linette Castillo-Pichardo, Tessa Humphries-Bickley, Columba De La Parra, Ingrid Forestier-Roman, Magaly Martinez-Ferrer, Eliud Hernandez, Cornelis Vlaar, Yancy Ferrer-Acosta, Anthony V. Washington, Luis A. Cubano, Jose Rodriguez-Orengo, Suranganie Dharmawardhane

    Published 2014-10-01
    Get full text
    Article
  9. 9
    Efficacy and delivery strategies of the dual Rac/Cdc42 inhibitor MBQ-167 in HER2 overexpressing breast cancer

    Efficacy and delivery strategies of the dual Rac/Cdc42 inhibitor MBQ-167 in HER2 overexpressing breast cancer by Luis E. Velázquez-Vega, Michael Rivera-Robles, Annelis O. Sánchez-Álvarez, Pablo E. Vivas-Mejía, Miciely Aponte-Reyes, Ailed M. Cruz-Collazo, Nilmary Grafals-Ruiz, Stephanie Dorta-Estremera, Eliud Hernández-O'Farrill, Cornelis P Vlaar, Suranganie Dharmawardhane

    Published 2024-06-01
    Get full text
    Article

Search Tools: